Download Department of Dermatology The Churchill Hospital Tel: 01865

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Urinary tract infection wikipedia , lookup

Kawasaki disease wikipedia , lookup

Germ theory of disease wikipedia , lookup

Infection control wikipedia , lookup

Childhood immunizations in the United States wikipedia , lookup

Globalization and disease wikipedia , lookup

Rheumatoid arthritis wikipedia , lookup

Behçet's disease wikipedia , lookup

Hospital-acquired infection wikipedia , lookup

African trypanosomiasis wikipedia , lookup

Graves' disease wikipedia , lookup

Signs and symptoms of Graves' disease wikipedia , lookup

Neuromyelitis optica wikipedia , lookup

Multiple sclerosis research wikipedia , lookup

Management of multiple sclerosis wikipedia , lookup

Multiple sclerosis signs and symptoms wikipedia , lookup

Sjögren syndrome wikipedia , lookup

Transcript
Department of Dermatology
The Churchill Hospital
Tel: 01865 228266
Fax: 01865 228260
VULVAL EROSIVE LICHEN PLANUS: COMMUNITY CARE
Lichen planus
Your patient has been attending our clinic with erosive (mucosal) lichen planus of the vulva and/or
perineum. She is currently in clinical remission, however this condition is a chronic one and
associated with an estimated 3-5% risk of malignant change. We currently recommend that,
following treatment, patients are followed up at 12 monthly intervals for life for signs of early
malignant change. For most patients we advise maintenance once or twice weekly Dermovate
ointment treatment (30g should last for more than 6 months). Please see discharge letter for
specific recommendations.
Community care is suitable for women with well controlled lichen planus (typically requiring less
than 30g Dermovate ointment or equivalent in any 6 month period), those who find travel difficult or
for those who prefer GP care. We propose that follow-up care is carried out by the General
Practitioner at 12 monthly intervals. In case your experience with this disease is limited we have
produced this advice sheet to help you. Please contact us or refer back if you have any concerns.
Vulval appearances and symptoms to expect in lichen planus:
 The disease usually presents with erosions/glazing at the vaginal introitus that are typically
edged by a lacy-white border. These erosions/glazing often persist. A referral back to clinic
is not necessary if the patient is asymptomatic.
 In some cases (hypertrophic disease) thickened white plaques may develop.
 Architectural change is common and there may be labial fusion with a contracted introitus,
and the clitoris may be buried.
 Secondary infection with candida (which may be clinically atypical) and bacteria may cause
worsening of symptoms. Please do a vulval swab and treat as appropriate.
 Remember that many patients are post-menopausal and may also need local Oestrogen
and lubricants eg Yes or Astroglide for intercourse.
What to look for:
 New hyperkeratotic areas that do not respond to Dermovate ointment once daily for 3
weeks.
 Very persistent, thickened or enlarging erosions.
 Nodule formation is a very suspicious sign and needs urgent referral. If a tumour is strongly
suspected urgent referral via the 2 week wait to gynaecology/oncology is preferable to
avoid delay in treatment. Gynaecology/oncology 2 week wait fax number 01865
231407.
 Scarring is common in this condition and there may be narrowing of the vagina. In active
vaginal lichen planus there may be vaginal discharge. Rarely the narrowing of the vaginal
introitus may be so severe that urinary retention may occur. Often we recommend Femmax
dilators, particularly if intercourse is infrequent, to help retain patency.
 Lichen planus can occur at other body sites eg the oral mucosa, scalp, oesophagus,
lacrimal ducts, extragenital skin and nails.
 Lichen planus has a strong association with other autoimmune diseases such as thyroid
disease, pernicious anaemia, vitiligo and diabetes. Please remain vigilant that these may
arise at any stage and may require treatment and monitoring.
Dr Susan Cooper
Consultant Dermatologist
SMC April 2015
SN Bernadette Miles-Marsh
Nurse Practitioner